Hepatocellular carcinoma (HCC) is a significant global health concern, particularly in regions like the Asia-Pacific, where chronic viral hepatitis and liver diseases contribute to its high incidence and mortality.
Japan considers adjusting clinical trial requirements to remove the need for local studies — report
Japan is rethinking its clinical trial requirements to address a lag in Japanese approvals for new drugs that are already available in other countries, according
November 14, 2023